000710 贝瑞基因
交易中 05-14 13:50:21
资讯
新帖
简况
贝瑞基因：5月11日董事高扬减持股份合计9.8万股
中金财经 · 05-12 22:09
贝瑞基因：5月11日董事高扬减持股份合计9.8万股
贝瑞基因：5月8日董事高扬减持股份合计10万股
证券之星 · 05-11 21:01
贝瑞基因：5月8日董事高扬减持股份合计10万股
贝瑞基因：5月7日董事高扬减持股份合计10.1万股
证券之星 · 05-08
贝瑞基因：5月7日董事高扬减持股份合计10.1万股
贝瑞基因：5月6日董事高扬减持股份合计10万股
证券之星 · 05-07
贝瑞基因：5月6日董事高扬减持股份合计10万股
股市必读：贝瑞基因(000710)股东户数5.74万户，较上期减少3.08%
证券之星 · 05-06
股市必读：贝瑞基因(000710)股东户数5.74万户，较上期减少3.08%
每周股票复盘：贝瑞基因（000710）Q1净利亏损1973万
证券之星 · 05-03
每周股票复盘：贝瑞基因（000710）Q1净利亏损1973万
贝瑞基因（000710）2026年一季报简析：净利润同比下降205.44%，公司应收账款体量较大
证券之星 · 05-01
贝瑞基因（000710）2026年一季报简析：净利润同比下降205.44%，公司应收账款体量较大
股市必读：贝瑞基因年报 - 第四季度单季净利润同比增长28.86%
证券之星 · 04-30
股市必读：贝瑞基因年报 - 第四季度单季净利润同比增长28.86%
图解贝瑞基因年报：第四季度单季净利润同比增长28.86%
证券之星 · 04-29
图解贝瑞基因年报：第四季度单季净利润同比增长28.86%
贝瑞基因：4月13日董事高扬减持股份合计9.81万股
中金财经 · 04-14
贝瑞基因：4月13日董事高扬减持股份合计9.81万股
贝瑞基因：4月10日董事高扬减持股份合计9.7万股
证券之星 · 04-13
贝瑞基因：4月10日董事高扬减持股份合计9.7万股
贝瑞基因：4月9日董事高扬减持股份合计90.65万股
证券之星 · 04-10
贝瑞基因：4月9日董事高扬减持股份合计90.65万股
贝瑞基因（000710）披露持股5%以上股东部分股份被司法强制执行的提示性公告，4月2日股价上涨0.84%
证券之星 · 04-02
贝瑞基因（000710）披露持股5%以上股东部分股份被司法强制执行的提示性公告，4月2日股价上涨0.84%
贝瑞基因（000710）披露董事辞职暨审计委员会委员更换公告，3月23日股价下跌6.57%
证券之星 · 03-23
贝瑞基因（000710）披露董事辞职暨审计委员会委员更换公告，3月23日股价下跌6.57%
贝瑞基因最新公告：董事赵辉辞职并补选张大可为审计委员会委员
证券之星 · 03-22
贝瑞基因最新公告：董事赵辉辞职并补选张大可为审计委员会委员
被315晚会点名的源创基因，实控人系贝瑞基因董事
市场资讯 · 03-15
被315晚会点名的源创基因，实控人系贝瑞基因董事
股市必读：贝瑞基因（000710）2月4日董秘有最新回复
证券之星 · 02-05
股市必读：贝瑞基因（000710）2月4日董秘有最新回复
股市必读：贝瑞基因（000710）1月30日董秘有最新回复
证券之星 · 02-02
股市必读：贝瑞基因（000710）1月30日董秘有最新回复
贝瑞基因：公司暂无此类明确计划
证券之星 · 01-30
贝瑞基因：公司暂无此类明确计划
贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%
证券之星 · 01-29
贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%
暂无数据
公司概况
公司名称：
成都市贝瑞和康基因技术股份有限公司
所属行业：
专业技术服务业
上市日期：
1997-04-22
主营业务：
成都市贝瑞和康基因技术股份有限公司的主营业务是出生缺陷三级预防及罕见病诊断。公司的主要产品是试剂、医学检测服务、基础科研服务、设备、智能体业务。
发行价格：
5.10
{"stockData":{"symbol":"000710","market":"SZ","secType":"STK","nameCN":"贝瑞基因","latestPrice":10.44,"timestamp":1778737821000,"preClose":10.59,"halted":0,"volume":9713600,"delay":0,"changeRate":-0.0142,"floatShares":330000000,"shares":354000000,"eps":-0.5944,"marketStatus":"交易中","change":-0.15,"latestTime":"05-14 13:50:21","open":10.63,"high":10.77,"low":10.43,"amount":103000000,"amplitude":0.0321,"askPrice":10.44,"askSize":114,"bidPrice":10.43,"bidSize":255,"shortable":0,"etf":0,"ttmEps":-0.5944,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778742000000},"marketStatusCode":2,"adr":0,"adjPreClose":10.59,"symbolType":"stock","openAndCloseTimeList":[[1778722200000,1778729400000],[1778734800000,1778742000000]],"highLimit":11.65,"lowLimit":9.53,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":353521465,"isCdr":false,"pbRate":2.58,"roa":"--","roe":"--","epsLYR":-0.5568,"committee":0.770374,"marketValue":3691000000,"turnoverRate":0.0295,"status":1,"floatMarketCap":3440000000},"requestUrl":"/m/hq/s/000710/tweets","defaultTab":"tweets","newsList":[{"id":"2634621099","title":"贝瑞基因：5月11日董事高扬减持股份合计9.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634621099","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634621099?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:09","pubTimestamp":1778594985,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月12日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因(000710)最新董监高及相关人员股份变动情况：2026年5月11日公司董事,高管高扬共减持公司股份9.8万股，占公司总股本为0.0277%。变动期间公司股价上涨3.82%，5月11日当日收盘报11.41元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下： 贝瑞基因的高管列表及最新持股情况如下： 该股最近90天内无机构评级。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/12/20260512743511.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/12/20260512743511.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260512/32218956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000710","BK0081","BK0028","BK0221","BK0042","BK0086","BK0102","BK0139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284656","title":"贝瑞基因：5月8日董事高扬减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284656","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634284656?lang=zh_cn&edition=full","pubTime":"2026-05-11 21:01","pubTimestamp":1778504490,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月11日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年5月8日公司董事,高管高扬共减持公司股份10.0万股，占公司总股本为0.0283%。变动期间公司股价上涨10.01%，5月8日当日收盘报10.99元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100033947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0028","BK0086","BK0042","BK0221","000710","BK0102","BK0081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633451374","title":"贝瑞基因：5月7日董事高扬减持股份合计10.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633451374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633451374?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:01","pubTimestamp":1778245313,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月8日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年5月7日公司董事,高管高扬共减持公司股份10.1万股，占公司总股本为0.0286%。变动期间公司股价下跌0.1%，5月7日当日收盘报9.99元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800041582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0221","BK0028","000710","BK0081","BK0139","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687140","title":"贝瑞基因：5月6日董事高扬减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687140","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633687140?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:01","pubTimestamp":1778158884,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月7日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年5月6日公司董事,高管高扬共减持公司股份10.0万股，占公司总股本为0.0283%。变动期间公司股价上涨0.1%，5月6日当日收盘报10.0元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700039540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","000710","BK0086","BK0081","BK0042","BK0139","BK0221","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633097336","title":"股市必读：贝瑞基因(000710)股东户数5.74万户，较上期减少3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633097336","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633097336?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:51","pubTimestamp":1778021468,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，贝瑞基因报收于9.99元，上涨0.71%，换手率1.48%，成交量4.89万手，成交额4865.91万元。来自公司公告汇总：贝瑞基因2026年第一季度归属于上市公司股东的净利润为-19,738,153.10元，同比下滑205.44%。股本股东变化股东户数变动近日贝瑞基因披露，截至2026年3月31日公司股东户数为5.74万户，较12月31日减少1827.0户，减幅为3.08%。总资产为2,215,763,912.61元，较上年度末下降3.00%；归属于上市公司股东的所有者权益为1,453,026,421.88元，较上年度末下降1.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600004420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0139","BK0221","BK0086","000710","BK0081","BK0102","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632081446","title":"每周股票复盘：贝瑞基因（000710）Q1净利亏损1973万","url":"https://stock-news.laohu8.com/highlight/detail?id=2632081446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632081446?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:28","pubTimestamp":1777768091,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，贝瑞基因报收于9.99元，较上周的9.68元上涨3.2%。本周，贝瑞基因4月30日盘中最高价报10.04元。股本股东变化股东户数变动截至2026年3月31日，贝瑞基因股东户数为5.74万户，较2025年12月31日减少1827户，减幅3.08%。户均持股数量由5967股增至6157股，户均持股市值为6.35万元。2026年一季度报告贝瑞基因2026年第一季度营业收入为210,215,582.68元，同比下降3.46%；归母净利润为-19,738,153.10元，同比下滑205.44%；扣非净利润为-19,707,266.42元，同比下滑435.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0028","BK0221","BK0081","BK0086","BK0042","BK0139","000710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632327660","title":"贝瑞基因（000710）2026年一季报简析：净利润同比下降205.44%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2632327660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632327660?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:36","pubTimestamp":1777588575,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期贝瑞基因发布2026年一季报。截至本报告期末，公司营业总收入2.1亿元，同比下降3.46%，归母净利润-1973.82万元，同比下降205.44%。本报告期贝瑞基因公司应收账款体量较大，当期应收账款占最新年报营业总收入比达58.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631854527","title":"股市必读：贝瑞基因年报 - 第四季度单季净利润同比增长28.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631854527","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631854527?lang=zh_cn&edition=full","pubTime":"2026-04-30 05:48","pubTimestamp":1777499296,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告贝瑞基因2025年全年主营收入9.3亿元，同比下降13.76%；归母净利润亏损1.97亿元，同比下降2.29%；扣非净利润亏损2.06亿元，同比下降7.44%。2025年第四季度单季主营收入2.44亿元，同比下降4.44%；单季归母净利润亏损1.44亿元，同比减亏28.86%；单季扣非净利润亏损1.53亿元，同比减亏25.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000017507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631658201","title":"图解贝瑞基因年报：第四季度单季净利润同比增长28.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631658201","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631658201?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:45","pubTimestamp":1777398328,"startTime":"0","endTime":"0","summary":"证券之星消息，贝瑞基因2025年年报显示，当年度公司主营收入9.3亿元，同比下降13.76%；归母净利润-1.97亿元，同比下降2.29%；扣非净利润-2.06亿元，同比下降7.44%；其中2025年第四季度，公司单季度主营收入2.44亿元，同比下降4.44%；单季度归母净利润-1.44亿元，同比上升28.86%；单季度扣非净利润-1.53亿元，同比上升25.51%；负债率34.15%，投资收益-353.78万元，财务费用646.19万元，毛利率43.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900004884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627417264","title":"贝瑞基因：4月13日董事高扬减持股份合计9.81万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627417264","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627417264?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:20","pubTimestamp":1776172842,"startTime":"0","endTime":"0","summary":"证券之星消息，根据4月14日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因(000710)最新董监高及相关人员股份变动情况：2026年4月13日公司董事,高管高扬共减持公司股份9.81万股，占公司总股本为0.0277%。变动期间公司股价下跌1.64%，4月13日当日收盘报10.18元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下： 贝瑞基因的高管列表及最新持股情况如下： 该股最近90天内无机构评级。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/14/20260414334564.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/14/20260414334564.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260414/32143615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0102","BK0221","BK0028","000710","BK0081","BK0139","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627551874","title":"贝瑞基因：4月10日董事高扬减持股份合计9.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627551874","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627551874?lang=zh_cn&edition=full","pubTime":"2026-04-13 21:01","pubTimestamp":1776085269,"startTime":"0","endTime":"0","summary":"证券之星消息，根据4月13日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年4月10日公司董事,高管高扬共减持公司股份9.7万股，占公司总股本为0.0274%。变动期间公司股价上涨0.0%，4月10日当日收盘报10.35元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300032064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0042","BK0102","BK0139","BK0221","BK0028","BK0081","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626111818","title":"贝瑞基因：4月9日董事高扬减持股份合计90.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626111818","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626111818?lang=zh_cn&edition=full","pubTime":"2026-04-10 21:01","pubTimestamp":1775826060,"startTime":"0","endTime":"0","summary":"证券之星消息，根据4月10日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年4月9日公司董事,高管高扬共减持公司股份90.65万股，占公司总股本为0.2564%。变动期间公司股价下跌3.18%，4月9日当日收盘报10.35元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000039343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000710","BK0042","BK0221","BK0028","BK0102","BK0139","BK0081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624138507","title":"贝瑞基因（000710）披露持股5%以上股东部分股份被司法强制执行的提示性公告，4月2日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624138507","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624138507?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:25","pubTimestamp":1775139918,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，贝瑞基因报收于10.81元，较前一交易日上涨0.84%，最新总市值为38.22亿元。该股当日开盘10.71元，最高11.41元，最低10.5元，成交额达2.43亿元，换手率为6.78%。公司于近日披露《关于持股5%以上股东所持部分股份被司法强制执行的提示性公告》。公告显示，贝瑞基因持股5%以上股东高扬先生因在国信证券的股票质押回购业务发生违约，被成渝金融法院裁定强制变现其所持公司3,535,214股股份，占公司总股本0.999%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000710","BK0139","BK0221","BK0102","BK0042","BK0081","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621746627","title":"贝瑞基因（000710）披露董事辞职暨审计委员会委员更换公告，3月23日股价下跌6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621746627","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621746627?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:56","pubTimestamp":1774259767,"startTime":"0","endTime":"0","summary":"贝瑞基因于近日披露《关于公司董事辞职暨更换第十届董事会审计委员会部分委员的公告》。公告显示，成都市贝瑞和康基因技术股份有限公司董事会于近日收到赵辉先生的书面辞职报告，赵辉先生因个人原因申请辞去第十届董事会董事、审计委员会委员职务。其辞职报告自2026年3月18日起生效。为确保审计委员会正常运作，公司第十届董事会第二十次会议审议通过选举独立董事张大可先生为审计委员会委员，任期至第十届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300028290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0221","BK0028","000710","BK0081","BK0139","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621717541","title":"贝瑞基因最新公告：董事赵辉辞职并补选张大可为审计委员会委员","url":"https://stock-news.laohu8.com/highlight/detail?id=2621717541","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621717541?lang=zh_cn&edition=full","pubTime":"2026-03-22 20:52","pubTimestamp":1774183922,"startTime":"0","endTime":"0","summary":"贝瑞基因(000710.SZ)公告称，公司董事会近日收到董事赵辉的书面辞职报告，其因个人原因辞去第十届董事会董事及审计委员会委员职务。鉴于其辞职将导致审计委员会成员低于法定最低人数，辞职自独立董事张大可正式就任审计委员会委员之日起生效。公司已于2026年3月18日召开董事会，选举张大可为审计委员会委员，任期至第十届董事会届满。调整后审计委员会由胡诗阳、李耀、张大可组成，胡诗阳任主任委员。赵辉未持有公司股份，辞职后不再担任公司及控股子公司任何职务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200009839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0028","BK0221","BK0086","BK0102","BK0042","000710","BK0081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619329101","title":"被315晚会点名的源创基因，实控人系贝瑞基因董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2619329101","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619329101?lang=zh_cn&edition=full","pubTime":"2026-03-15 21:22","pubTimestamp":1773580920,"startTime":"0","endTime":"0","summary":"被各种商家营销套路侵害权益？买到的商品出故障投诉无门？黑猫投诉平台全天候帮您解决消费难题。其中涉及名为源创基因的公司。另据企查查数据，该公司实控人赵辉系A股公司贝瑞基因董事。投资者据此操作，风险自担。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-15/doc-inhrascp9378264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0081","BK0221","BK0102","BK0086","BK0042","BK0139","000710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609639495","title":"股市必读：贝瑞基因（000710）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609639495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609639495?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:55","pubTimestamp":1770227714,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，贝瑞基因报收于12.28元，上涨0.57%，换手率2.34%，成交量7.7万手，成交额9372.63万元。董秘最新回复投资者： 尊敬的董秘你好！关于AI赋能的商业模式创新，AI的引入可能催生新的服务模式。公司在AI+基因测序领域已有哪些布局和落地成果？当日关注点来自交易信息汇总：2月4日主力资金净流出495.9万元，散户资金净流入584.55万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0221","BK0081","BK0086","BK0102","000710","BK0042","BK0139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608886399","title":"股市必读：贝瑞基因（000710）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608886399?lang=zh_cn&edition=full","pubTime":"2026-02-02 02:07","pubTimestamp":1769969233,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，贝瑞基因报收于12.05元，下跌3.91%，换手率4.36%，成交量14.37万手，成交额1.74亿元。交易信息汇总1月30日主力资金净流出1964.56万元；游资资金净流出1686.42万元；散户资金净流入3650.98万元。公司公告汇总成都市贝瑞和康基因技术股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为-25,000万元至-17,000万元，扣除非经常性损益后的净利润为-24,500万元至-16,500万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0081","BK0139","000710","BK0102","BK0086","BK0221","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607604801","title":"贝瑞基因：公司暂无此类明确计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2607604801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607604801?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:53","pubTimestamp":1769777603,"startTime":"0","endTime":"0","summary":"证券之星消息，贝瑞基因(000710)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好！美国知名投资者“木头姐”大举投资基因公司TEM，我看了下此公司和公司业务高度契合，请问公司未来有没有想邀请像“木头姐”一样的投资者及机构来战略投资公司，把公司做大做强。贝瑞基因回复：投资人您好！公司暂无此类明确计划，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000043738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0139","BK0221","BK0086","000710","BK0081","BK0102","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607903627","title":"贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607903627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607903627?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:03","pubTimestamp":1769698996,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，贝瑞基因报收于12.54元，较前一交易日上涨0.64%，最新总市值为44.33亿元。该股当日开盘12.38元，最高12.88元，最低12.12元，成交额达2.09亿元，换手率为5.04%。近日，成都市贝瑞和康基因技术股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为-25,000万元至-17,000万元，扣除非经常性损益后的净利润为-24,500万元至-16,500万元。本次业绩预告未经审计，最终数据以2025年年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0042","BK0081","BK0086","BK0221","BK0139","BK0102","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778737822587,"stockEarnings":[{"period":"1week","weight":0.059},{"period":"1month","weight":0.0403},{"period":"3month","weight":-0.1425},{"period":"6month","weight":-0.2326},{"period":"1year","weight":-0.2414},{"period":"ytd","weight":-0.062}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0637},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2571},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都市贝瑞和康基因技术股份有限公司","boardCode":"AI0074","boardName":"专业技术服务业","stockholders":"57422人(较上一季度减少3.08%)","perCapita":"5738股","listingDate":"1997-04-22","address":"四川省成都市龙泉驿区经济技术开发区(龙泉驿区)成都汽车城大道333号","registeredCapital":"35352万元","survey":" 成都市贝瑞和康基因技术股份有限公司的主营业务是出生缺陷三级预防及罕见病诊断。公司的主要产品是试剂、医学检测服务、基础科研服务、设备、智能体业务。","listedPrice":5.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝瑞基因,000710,贝瑞基因股票,贝瑞基因股票老虎,贝瑞基因股票老虎国际,贝瑞基因行情,贝瑞基因股票行情,贝瑞基因股价,贝瑞基因股市,贝瑞基因股票价格,贝瑞基因股票交易,贝瑞基因股票购买,贝瑞基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}